Welcome to the Norwegian Experimental Cell Transplantation homepage
Hanne Scholz Group leader
The research group was established at the Institute of Surgical Research in 2005 and has focused on the development of new strategies to counteract the harmful effects of islet cells before transplantation, and to strengthen islet growth and function after transplantation.
Waage A, Khan A, Labori KJ, Birkeland KI, Scholz H, Jensen TG, Tholfsen T, Line PD, Hagness M(2024) Implementation of a nationwide program for total pancreatectomy and islet autotransplantation in chronic pancreatitis: A Scandinavian single-center observational study Scand J Surg, 14574969241298985(in press) DOI 10.1177/14574969241298985, PubMed 39558154
Berishvili E, Piemonti L, de Koning EJP, Lindstedt S, Scholz H, Scott WE, Auxenfans C, Johnson P, Martin DE, Gunther P, Mey D, Potena L, Thaunat O(2024) ESOT Roadmap for Advanced Therapy Medicinal Products in Transplantation: Navigating Regulatory Challenges to Enhance Access and Care Transpl Int, 37, 13485 DOI 10.3389/ti.2024.13485, PubMed 39469665
Scholz H, Sordi V, Piemonti L(2024) Cautious Optimism Warranted for Stem Cell-Derived Islet Transplantation in Type 2 Diabetes Transpl Int, 37, 13358 DOI 10.3389/ti.2024.13358, PubMed 39131791